Esperas Pharma Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Esperas Pharma General Information

Description

Developer of oral investigational therapeutics intended to inhibit cancer cell division for advanced or metastatic cancer treatment. The company focuses on research and clinical development of targeted oral therapies that disrupt cellular proliferation in cancer, enabling oncology healthcare providers and researchers to access novel treatment candidates that aim to expand options for patients with challenging cancers.

Contact Information

Website
www.esperasinc.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 810-1470 rue Peel
  • Montreal, Quebec H3A 1T1
  • Canada
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
HealthTech, Life Sciences, Oncology
Corporate Office
  • 810-1470 rue Peel
  • Montreal, Quebec H3A 1T1
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Esperas Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 25-Apr-2026 Completed Out of Business
2. Later Stage VC 21-Feb-2023 Completed Clinical Trials - Phase 1
1. Early Stage VC 13-Apr-2015 $16.5M $16.5M Completed Startup
To view Esperas Pharma’s complete valuation and funding history, request access »

Ready to get started?

Request a free trial

Esperas Pharma FAQs

  • When was Esperas Pharma founded?

    Esperas Pharma was founded in 2015.

  • Where is Esperas Pharma headquartered?

    Esperas Pharma is headquartered in Montreal, Canada.

  • What industry is Esperas Pharma in?

    Esperas Pharma’s primary industry is Biotechnology.

  • Is Esperas Pharma a private or public company?

    Esperas Pharma is a Private company.

  • What is Esperas Pharma’s current revenue?

    The current revenue for Esperas Pharma is .

  • How much funding has Esperas Pharma raised over time?

    Esperas Pharma has raised $16.5M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process